Terbium 161 DOTATATE PRRT

N/A

Report date: 2026/03/04 20:01:44

NME

Base Information

Drug NameTerbium 161 DOTATATE PRRT

Drug Alias NameAuger-emitter Peptide Receptor Radionuclide Therapy (Tata Memorial Centre)

ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Radiation-emitting products > Nuclides > Terbium > 161Tb

Mechanisms of ActionSomatostatin receptor 2 modulators

TargetsSomatostatin receptor 2

Therapy Area/IndicationsCarcinoma, NeuroendocrineNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTata Memorial Centre

China Registration ClassN/A

Develop Information

Active CompaniesTata Memorial Centre

Inactive CompaniesN/A

Active IndicationsCarcinoma, NeuroendocrineNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A